Viatris (VTRS)

[Tlsmd]

Here is more DD
Search for Mylan NV specific news
Search Acro

Amazon Has Discussed Pharmacy Business With Generic Drugmakers: Report -- MarketWatch
12 hours 16 minutes ago - DJNF
Amazon.com Inc. (AMZN) has had early talks with generic drug makers like Mylan NV (MYL) and Novartis AG's (NOVN.EB) Sandoz about a potential entry into the pharmacy business (http://www.marketwatch.com/story/is-amazon-getting-into-the-pharmacy-business-this-is-what-you-need-to-know-2017-10-09), according to a Thursday report. CNBC reported (https://www.cnbc.com/2017/11/30/amazon-holding-exploratory-talks-with-generic-drug-makers.html) Thursday that health care investment bank Leerink confirmed that a Sandoz executive recently spoke with Amazon about its plans to enter the health-care market in the U.S., and other anonymous sources confirmed the talks. Leerink analyst David Larsen has said that Amazon's entry into the pharmaceutical sales chain (http://www.marketwatch.com/story/amazons-getting-into-the-pharmacy-business-is-a-matter-of-when-not-if-2017-10-06) in some regard "is a matter of when, not if." Amazon shares ticked up slightly in after-hours trading Thursday, gaining about 0.1%; Mylan seemed to get the healthiest bump from the report, gaining 4.5%.
-Jeremy C. Owens

For more from MarketWatch: http://www.marketwatch.com/newsviewer

(END) Dow Jones Newswires

November 30, 2017 17:23 ET (22:23 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

« Back to Stocks News

CFRA Research Notes
CFRA KEEPS HOLD OPINION ON SHARES OF MYLAN N.V.
Monday 11/06/2017 11:48 AM ET - S&P Capital IQ's Research Notes
CFRA KEEPS HOLD OPINION ON SHARES OF MYLAN N.V.
Tuesday 10/31/2017 02:17 PM ET - S&P Capital IQ's Research Notes
News Pulse
News Pulse



Top Stories
What Scottrade Customers are Reading...
View more headlines






Mylan NV Events:
Click any event category to view recent market activity within that category
Economics62
IPO & SPO0
Earnings0
Dividends0
Splits0
View All Calendar Activity